When a woman is diagnosed with breast cancer, the clinical machinery swings into motion: imaging, staging, oncology referrals ...

Susan Cantrell, CEO of AMCP, explained in an interview with The American Journal of Managed Care® ( AJMC®) that the ...

Tirzepatide (Mounjaro; Eli Lilly), a dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide ...

Nancy L. Lewis, MD, MBS, FACP, reflects on the career journey that led her to her new role as chief scientific officer (CSO) ...

These findings, reported in 2 posters presented at the 2026 American Academy of Dermatology Annual Meeting, highlight ...

Among the most striking findings, 86.1% of patients treated with bimekizumab were completely flare-free across the entire ...

Clinically significant insomnia, elevated OSA risk, and insufficient sleep duration were markedly higher in rural Appalachian ...

When asked about behavioral support, 56% of employed adults said they would self-pay for a GLP-1 if their employer offered a ...

Her career has taken her from treating patients to developing new medicines for biopharma, and now Nancy L. Lewis, MD, MBS, ...

Most patients initiated full-dose ibrutinib, while reduced starting doses clustered in older, more comorbid, poorer ECOG ...

Repeated noninvasive stool DNA testing could offer greater real-world effectiveness than colonoscopy for colorectal cancer ...

Major US health insurers have eliminated roughly 11% of prior authorization requirements and introduced new ...